March 2, 2022 – Beyond COVID-19, President Joe Biden on Tuesday hit on a number of different well being care priorities in his first State of the Union, together with a warning that the administration would scrutinize personal investor possession of nursing properties and that Medicare was going to “set higher standards for nursing homes and make sure your loved ones get the care they deserve and expect.”

Biden, in his deal with to a joint session of Congress, additionally pledged to guard entry to well being care, to protect a “woman’s right to choose,” to advance maternal well being care, and to guard youthful transgender Americans, calling a spate of state legal guidelines concentrating on them “wrong.”

The president additionally stated he was doubling down on the Cancer Moonshot program’s promise “to end cancer as we know it,” asking Congress to fund his proposed Advanced Research Projects Agency for Health, which might be tasked with discovering breakthroughs associated to most cancers, Alzheimer’s, diabetes, and different ailments.

What’s extra, Biden stated he plans to behave to “get rid of outdated rules that stop doctors from prescribing treatments” for opioid habit.

“I believe in recovery, and I celebrate the 23 million Americans in recovery,” he stated.

The State of the Union deal with got here after the administration earlier within the day introduced a brand new effort to enhance Americans’ psychological well being, and stated the White House would work with Congress to broaden telehealth and combine psychological well being with major care. Biden’s fiscal 2023 finances, which might take impact Oct. 1, will double funding for major and behavioral well being integration applications.

Acknowledging State of the Union visitor Frances Haugen, a former Facebook worker who uncovered the corporate’s algorithms concentrating on youngsters, Biden stated, “We must hold social media platforms accountable for the national experiment they’re conducting on our children for profit.”

“It’s time to strengthen privacy protections, ban targeted advertising to children, demand tech companies stop collecting personal data on our children,” he stated.

In response to this a part of the president’s deal with, American Academy of Pediatrics President Moira Szilagyi, MD, stated in a press release that the group was joyful the administration was proposing to “protect the digital privacy and well-being of children and adolescents.”

Last fall, the AAP made a nationwide emergency declaration on youngsters’s psychological well being as a result of the pandemic worsened psychological well being points. Szilagyi stated the AAP “welcomes tonight’s recognition of children’s mental health as a national priority and looks forward to what comes next.”

The American Psychological Association and the American Medical Association additionally applauded Biden’s psychological well being proposals, particularly for elevating youngsters’s wants.

“COVID-19 has had a devastating impact on mental health, especially for school-aged children and for communities that have been historically marginalized or minoritized,” AMA President Gerald E. Harmon, MD, stated in a press release.

But the star of the night gave the impression to be Joshua Davis, a seventh grader with sort 1 diabetes who beamed from the primary girl’s field as Biden spoke.

“For Joshua, and for the 200,000 other young people with type 1 diabetes, let’s cap the cost of insulin at $35 a month so everyone can afford it,” the president stated through the deal with.

“Drug companies will still do very well,” he stated, noting that Medicare ought to be allowed to barter decrease costs for prescribed drugs.

The insulin cap proposal — just for these with personal insurance coverage — is contained in Biden’s Build Back Better plan, which has been stymied within the Senate.

The Endocrine Society praised Biden for saying he’ll tackle drug prices, significantly insulin.

In a press release, the society famous that greater than 37 million Americans have diabetes, with 3 million beginning on insulin inside a 12 months of being recognized.

Those with sort 1 depend on insulin to outlive, the society stated.

“We urge Congress to come together and pass legislation to make insulin affordable as soon as possible,” stated the assertion.

The post Non-COVID Highlights From Biden’s State of the Union Address appeared first on Healthy and Slim Life.

Feb. 15, 2022 — Robert Califf, MD, on Tuesday narrowly received Senate affirmation to as soon as once more function the commissioner of the FDA, overcoming protest votes from lawmakers about abortion and opioid points.

The Senate voted 50-46 in favor of Califf’s nomination. A heart specialist lengthy affiliated with Duke University and a famous skilled on scientific trials, Califf additionally led the FDA from February 2016 by means of January 2017.

In 2016, the Senate confirmed him as FDA chief in an 89-4 vote. At that point, Sen. Joe Manchin, D-WV, and some different senators mentioned they had been involved Califf’s hyperlinks to the drug business would hamper his capability to control drugmakers, notably when it comes to guidelines on prescription painkillers.

Manchin additionally objected to Califf’s second nomination as FDA commissioner, as did a number of fellow Democrats, together with Sen. Edward Markey of Massachusetts. In a press release issued after the Tuesday vote, Markey mentioned he has “consistently raised concerns about the FDA’s egregious mishandling of opioid approvals and its role in enabling the current opioid epidemic.”

“To date, the FDA still has not implemented many of the reforms necessary to ensure that it is fulfilling its role as our nation’s top pharmaceutical cop on the beat,” Markey mentioned. “I have not received any real commitment from Dr. Califf to truly reform the FDA or to learn from the failures that fueled this public health crisis.”

This time, Califf misplaced assist amongst Republican senators resulting from objections raised by teams searching for to finish ladies’s entry to abortion. Susan B. Anthony List and National Right to Life requested senators in a January letter to oppose Califf’s nomination, citing their objections to how the FDA dealt with reporting of hostile occasions from abortions by medicine throughout Califf’s tenure.

But some Republicans supported Califf within the Tuesday vote. Sens. Roy Blunt of Missouri, Richard Burr of North Carolina, Susan Collins of Maine, Lisa Murkowski of Alaska, Mitt Romney of Utah, and Pat Toomey of Pennsylvania all voted in his favor

On Monday, Sen. Patty Murray, D-WA, chairwoman of the Senate Health, Education, Labor and Pensions Committee, urged her colleagues to vote for Califf to provide the FDA robust management to sort out pressing well being wants such because the opioid disaster, youth tobacco use, antimicrobial resistance, and inequities in well being care.

“At this critical moment, we need a trusted hand to lead the FDA,” she mentioned in a flooring speech. Califf’s earlier service on the FDA and his years spent as a analysis scientist “give him the experience to take on this challenge.”

Separately, three former FDA commissioners on Tuesday revealed an opinion article that appeared inThe Hill. Republican presidents nominated two of those former FDA chiefs: Scott Gottlieb, MD, and Mark McClellan, MD. The third, Margaret Hamburg, MD, was nominated by President Barack Obama, as was Califf for his first time as FDA chief.

There’s an pressing want for a confirmed chief on the FDA because the U.S. seeks to maneuver past the pandemic, the previous FDA chiefs wrote. The work forward consists of continued efforts with vaccines in addition to efforts to bolster medical provide chains, they mentioned.

Califf “knows how to advance the safe development and use of medical products and to bring a sound, science-based foundation to the FDA’s regulatory actions. Because of this, he has earned the confidence of FDA’s professional career staff, as well as a broad base of patient groups, academic experts, medical professionals and public health organizations,” Gottlieb, Hamburg, and McClellan wrote.

The article additionally was signed by former Centers for Medicare and abortion Services Administrator Andy Slavitt, who served within the Obama administration.

Support of Medical Community

The American Heart Association on Tuesday issued a press release congratulating Califf on his second affirmation after the Senate vote.

“With a distinguished career in public service and a long-time volunteer leader at the American Heart Association, Dr. Califf has honed his ability to communicate and build trust with diverse constituencies,” CEO Nancy Brown mentioned within the assertion. “He will use his experience as a cardiologist to safeguard the health and well-being of people throughout the country, and his background in research to prioritize science and evidence-based policymaking.”

Califf was additionally backed by the Association of American Medical Colleges, American Academy of Pediatrics, American Academy of Family Physicians, and American College of Physicians when he was nominated for the position final yr by President Joe Biden.

The post Biden’s FDA Chief Nominee Narrowly Wins Senate Confirmation appeared first on Healthy and Slim Life.

Dec. 14, 2021 — Robert M. Califf, MD, plans to take a detailed take a look at federal insurance policies on opioid prescriptions in his anticipated second flip on the high U.S. regulator of medical merchandise, in addition to hold nearer tabs on the efficiency of medication cleared with accelerated approvals.

Califf on Tuesday fielded questions at a Senate listening to about his nomination by President Joe Biden to function FDA administrator), a job wherein served within the Obama administration. He additionally spoke about the necessity to bolster the nation’s capacity to take care of an sufficient provide of key medical merchandise, together with medication.

Members of the Senate Health, Education, Labor and Pensions Committee, which is dealing with Califf’s nomination, had been largely cordial and supportive in the course of the listening to. Sen. Patty Murray (D-WA), the committee chair, and the panel’s high Republican, Sen. Richard Burr of North Carolina addressed Califf in the course of the listening to as if he would quickly serve once more because the FDA’s chief. Both had been among the many senators who voted 89-4 to verify Califf in a February 2016 vote.

Califf “was previously confirmed to lead FDA in an overwhelming bipartisan vote and I look forward to working with him again to ensure FDA continues to protect families across the country, uphold the gold standard of safety and effectiveness, and put science and data first,” Murray mentioned.

Less obsessed with Califf was Sen. Bernie Sanders (I-VT), who was among the many seven senators who didn’t vote on Califf’s nomination in 2016.

Sanders objected in 2016 to Califf’s ties to the pharmaceutical trade and he did so once more Tuesday. A famous chief in conducting scientific trials, Califf has labored with many drugmakers. But on the listening to, Califf mentioned he concurs with Sanders on an concept strongly opposed by the pharmaceutical trade.

In response to Sanders’ query, Califf mentioned he already is “on record as being in favor of Medicare negotiating with the industry on prices.”

The FDA wouldn’t take direct half in negotiations, as this work could be dealt with by the Centers for Medicare and Medicaid Services. Democrats wish to give Medicare some negotiating authority by means of their sweeping Build Back Better Act.

People within the United States are dismayed over each the price of pharmaceuticals and the widespread distribution of prescription painkillers that helped gasoline the present opioid epidemic, Sanders advised Califf. Many folks might be involved about an FDA commissioner who has benefited from shut ties to the trade, Sanders mentioned.

“How are they going to believe that you’re going to be an independent and strong voice against this enormously powerful, special interest?” Sanders requested.

“I’m totally with you on the concept that the price of pharmaceuticals is way too high in this country,” Califf mentioned in reply.

Califf was paid $2.7 million in wage and bonus by Verily Life Sciences, the biomedical analysis group operated by Alphabet Inc., father or mother firm of Google, in accordance with his federal monetary disclosure. He additionally reported holding board positions with pharmaceutical corporations AmyriAD and Centessa Pharmaceuticals PLC.

Bloomberg Government reported that Califf has ties to about 16 different analysis organizations and biotech corporations. Bloomberg Government additionally mentioned that in his earlier FDA service, Califf stored a whiteboard in his workplace that listed all of the actions and initiatives that required his recusal, citing as a supply Howard Sklamberg, who was a deputy commissioner below Califf.

“He was very, very, very careful,” Sklamberg, who’s now an legal professional at Arnold & Porter LLP, advised Bloomberg Government.

‘Work to Do’ on Opioids

Senators looped again repeatedly to the subject of opioids throughout Califf’s listening to, reflecting deep issues in regards to the FDA’s efforts to warn of the dangers of prescription painkillers.

There had been an estimated 100,306 drug overdose deaths within the U.S. within the 12 months ending in April, a rise of 28.5% from the 78,056 deaths throughout the identical interval the yr earlier than, in accordance with the CDC.

Califf mentioned he plans to give attention to what data the FDA conveys to the general public in regards to the dangers of prescription painkillers, together with a take a look at what the labels for these merchandise say.

“I am committed to do a comprehensive review of the status of opioids, early in my tenure,” Califf mentioned.

Califf indicated that physicians are nonetheless too fast to supply extra doses of those medicines, regardless of years of efforts to restrain their use. He mentioned he is aware of family members who got 30-day prescriptions for opioids after minor surgical procedure.

“So I know we have work to do,” Califf mentioned.

Concerns in regards to the FDA’s earlier work in managing opioids has led to protests from just a few Democratic senators in regards to the prospect of Biden nominating the appearing FDA commissioner, Janet Woodcock, MD, for the everlasting submit.

At the listening to, Sen. Ben Ray Luján (D-NM) raised the case of the FDA’s approval of the highly effective Zohydro painkiller. The company authorized that drug regardless of an 11-2 vote in opposition to it by the FDA’s Anesthetic and Analgesic Drug Advisory Committee.

Luján requested Califf what he would do if an FDA advisory committee voted “overwhelmingly” in opposition to recommending approval of a medication, as occurred within the Zohydro case.

While not talked about by Luján on this alternate in the course of the listening to with Califf, the FDA workers’s rejection of suggestions of advisory committees has been a rising concern amongst researchers.

The company final yr authorized aducanumab (Aduhelm, Biogen), a drug for Alzheimer’s illness, dismissing the recommendation of its Peripheral and Central Nervous System Drugs Advisory Committee. That choice triggered the resignation of a number of members of the panel. The FDA workers additionally earlier rejected the conclusion nearly all of members of the identical advisory committee provided in 2016 on eteplirsen (Exondys 51), a drug for Duchenne muscular dystrophy.

Califf advised Luján he had finished current analysis into how typically the FDA workers doesn’t concur with the suggestions of an advisory committee. He mentioned the FDA takes a unique plan of action in about 25% of circumstances. In about three-quarters of these circumstances, the FDA workers opts for a “more stringent” strategy concerning permitting the general public entry to the drug, versus a extra beneficiant one as seen within the Zohydro, Aduhelm and Exondys 51 circumstances.

Still, Califf mentioned that when there’s an 11-2 advisory committee vote in opposition to suggestion of a product, “the leaders at FDA really need to take a close look” at what’s occurring.

Question on Accelerated Approvals

The FDA’s approval of aducanumab drew consideration to a debate already underway about conditional clearances generally known as accelerated approvals.

The FDA has used this path because the Nineties to hurry entry to medication for critical circumstances. The trade-off for early entry is that the company generally makes the flawed name primarily based on preliminary findings, and clears a medication later discovered to not profit sufferers as anticipated.

The FDA’s most cancers division is within the midst of public efforts to handle circumstances the place drugmakers haven’t been in a position to ship research that assist accelerated approvals of their oncology medication. In addition, the Office of the Inspector General of the Department of Health and Human Services introduced in August that it’s reviewing the FDA’s dealing with of the accelerated approval course of.

At Tuesday’s listening to, Burr grilled Califf about how he would reply to calls to vary how the FDA handles the accelerated-approval course of.

“Can you commit to me and to patients who may rely on cutting-edge treatments that you will not support efforts to narrow this pathway or raise the bar for drugs to be approved under those pathways?” Burr requested Califf.

Califf responded by saying he was “a fan of accelerated approval — for the right conditions.”

Earlier, in his opening assertion, Califf had mentioned his mom benefited straight from the accelerated approval of latest medication for a number of myeloma. Califf advised Burr that he had spent “countless hours with patient groups” and understands the necessity to pace the approval of medicines for critical ailments.

But the FDA additionally has to verify it holds up its finish of the discount struck with accelerated approvals. This entails checking on how these medicines work as soon as they’re marketed.

“We’re accepting that there’s more uncertainty,” Califf mentioned. “That means we’ve got to have a better system to evaluate these products as they’re used on the market. And I think there are ways that we can do that now. Technology is making this possible in ways that it just was not possible before.”

Worries in regards to the Medical Supply Chain

Sen. Susan Collins (R-ME) requested Califf in regards to the vulnerability of the U.S. medical system to disruptions of the provision chain. She raised issues about China’s dominance in antibiotic manufacturing for example. She requested if Congress might do extra to encourage home manufacturing of medical provides, similar to by providing tax incentives.

Califf advised Collins he shared her concern in regards to the US manufacturing of components utilized in each branded and generic medication. He mentioned he not too long ago has served on a committee of the National Academy of Medicine that’s analyzing provide chain points.

This committee will quickly launch a report with particular suggestions, Califf mentioned.

“We don’t have enough competitive entities in what’s become sort of a commodity business” of drug manufacturing, Califf mentioned. “So we need a number of steps to make the system more resilient.”

The post Biden’s Pick for FDA Gets Bipartisan Support During Hearing appeared first on Healthy and Slim Life.

[MUSIC PLAYING]

SPEAKER: How does a COVID-19

mRNA vaccine work?

COVID vaccines are actually

obtainable.

Some of the COVID-19 vaccines

are mRNA vaccines, however what does

this imply?

mRNA vaccines are

totally different from conventional

vaccines.

mRNA vaccines do not expose you

to any actual virus as an alternative,

they’re made with messenger

Ribonucleic Acid or mRNA.

This is a kind of molecule that

provides directions to the cell

for how one can make totally different sorts

of proteins.

mRNA molecules are

a pure a part of our cells

and the way our our bodies work.

Researchers have been working

with mRNA vaccines

for a few years.

They are made extra simply

and safely in a lab

than a vaccine that makes use of

a virus.

Because of this they’ll additionally

be made sooner.

The COVID-19 mRNA vaccines

have handed many exams in labs

and in 1000’s of individuals,

and meet strict requirements

from the FDA.

So how do these vaccines work?

First, a COVID-19 mRNA vaccine

is injected right into a muscle

in your higher arm.

Some muscle cells take the mRNA

directions within the vaccine

and make a innocent piece

of a protein known as

a spike protein.

This protein is discovered

on the surface of the SARS-CoV-2

virus that causes COVID-19.

The muscle cells then destroy

the directions for how one can make

the spike protein.

The mRNA by no means goes

into the nucleus of your cells

the place your DNA is saved.

The newly made spike protein now

sits on the floor

of the muscle cells.

Your immune system senses

the spike protein

as a overseas menace to destroy,

it begins making antibodies

to struggle something

with that spike protein on it.

This will assist your physique’s

immune system acknowledge

and struggle the true virus if it

ever reveals up.

It’s like recognizing somebody

by the hat they put on.

Your physique is then

ready to identify COVID-19

and struggle it off earlier than it grows

in your physique’s cells.

Fast info to recollect

about COVID-19 mRNA vaccines.

They assist get your physique

able to struggle off the COVID-19

virus earlier than it makes you sick,

they do not use

any dwell, lifeless, or weak virus,

they can not provide you with COVID-19,

they do not have an effect on your DNA.

Want to be taught extra,

go to cdc.gov to seek out extra

details about mRNA vaccines.

You can even be taught extra about

how the vaccines had been accredited

at fda.gov.

[SWOOSH]

[MUSIC PLAYING]

The post Biden’s COVID Vaccine Mandates: Where Do They Stand? appeared first on Healthy and Slim Life.